| Literature DB >> 10572613 |
P Schöffski1, P Chollet, A Ganser, K H Wiese, E Rambusch, M J de Vries, A Hanauske.
Abstract
We report the case of an unresected, metastatic gastric cancer, which was treated with a very short course of the oral 5-fluorouracil (5-FU) prodrug S-1. The patient had to discontinue chemotherapy during the first treatment cycle due to severe toxicity, but achieved a pathologically confirmed, long-term complete response of her primary tumour, a diffuse-type poorly differentiated adenocarcinoma.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10572613 DOI： 10.1023/a:1008364601010
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976